Research ArticleTheranostics
Bridging the Imaging Gap: PSMA PET/CT Has a High Impact on Treatment Planning in Prostate Cancer Patients with Biochemical Recurrence—A Narrative Review of the Literature
Özgül Ekmekcioglu, Martijn Busstra, Natalie Desiree Klass and Fred Verzijlbergen
Journal of Nuclear Medicine October 2019, 60 (10) 1394-1398; DOI: https://doi.org/10.2967/jnumed.118.222885
Özgül Ekmekcioglu
1Nuclear Medicine Department, Sisli Etfal Education and Research Hospital, Istanbul, Turkey
Martijn Busstra
2Urology Department, Erasmus Medical Center, Rotterdam, The Netherlands
Natalie Desiree Klass
3Radiation Oncology Department, Bern University Hospital, Bern, Switzerland; and
Fred Verzijlbergen
4Radiology and Nuclear Medicine Department, Radboud University Medical Center, Nijmegen, The Netherlands
Article Figures & Data
Additional Files
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 10
October 1, 2019
Bridging the Imaging Gap: PSMA PET/CT Has a High Impact on Treatment Planning in Prostate Cancer Patients with Biochemical Recurrence—A Narrative Review of the Literature
Özgül Ekmekcioglu, Martijn Busstra, Natalie Desiree Klass, Fred Verzijlbergen
Journal of Nuclear Medicine Oct 2019, 60 (10) 1394-1398; DOI: 10.2967/jnumed.118.222885
Bridging the Imaging Gap: PSMA PET/CT Has a High Impact on Treatment Planning in Prostate Cancer Patients with Biochemical Recurrence—A Narrative Review of the Literature
Özgül Ekmekcioglu, Martijn Busstra, Natalie Desiree Klass, Fred Verzijlbergen
Journal of Nuclear Medicine Oct 2019, 60 (10) 1394-1398; DOI: 10.2967/jnumed.118.222885